Document Classification

Section Type: RESULTS

Text: At 12 months after randomization, the n-3 PUFAs group and the placebo group differed significantly (p < 0. 001) in regard to : 1) LV ejection fraction (increased by 10. 4 % and decreased by 5. 0 %, respectively) ; 2) peak VO (2) (increased by 6. 2 % and decreased by 4. 5 %, respectively) ; 3) exercise duration (increased by 7. 5 % and decreased by 4. 8 %, respectively) ; and 4) mean New York Heart Association functional class (decreased from 1. 88 0. 33 to 1. 61 0. 49 and increased from 1. 83 0. 38 to 2. 14 0. 65, respectively).